Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Anemia

Free Subscription Articles published in Blood Retrieve available abstracts of 184 articles: HTML format

Single Articles

August 2026
1. ESRICK EB, Lehmann L, Federico A, Vincon H, et al
   Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in sickle cell disease.
   Blood. 2026;148:957-966.
   PubMed     Abstract available
   
   
   
2. WARNY M, Glenthoj A, Afzal S, Wei S, et al
   No overall increased risk of death in individuals with sickle cell trait: a study of 467 779 general population adults.
   Blood. 2026;148:1033-1039.
   PubMed     Abstract available
   
   
   
3. HOCHSMANN B, Schafhausen P, Beier F, Heuser M, et al
   Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.
   Blood. 2026 Aug 18:blood.2025032682. doi: 10.1182/blood.2025032682.
   PubMed     Abstract available
   
   
   
4. CHETLAPALLI K, Ito S, Ng DQ, Sra M, et al
   Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis.
   Blood. 2026;148:896-909.
   PubMed     Abstract available
   
   
   
5. GROARKE EM, Gutierrez-Rodrigues F, Patel BA
   How I utilize somatic alterations in the diagnosis, risk stratification, and therapy of hypocellular bone marrow failure.
   Blood. 2026;148:818-830.
   PubMed     Abstract available
   
   
   
6. LEBENSBURGER J
   Balancing risk: anemia or albuminuria when using ACEi/ARB?
   Blood. 2026;148:652-653.
   PubMed    
   
   
   July 2026
7. VIATCHENKO-KARPINSKI V, Khasabova IA, Johns M, Neal L, et al
   Chronic pain in sickle cell disease: a role for lysophosphatidic acid.
   Blood. 2026;148:623-633.
   PubMed     Abstract available
   
   
   
8. ZHANG Y, Wang X
   A case of vitreoretinal PTLD after HSCT for aplastic anemia.
   Blood. 2026;148:521.
   PubMed    
   
   
   
9. ROSATO BE, Marra R, Martone S, Manno M, et al
   Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red blood cell and iron disorders.
   Blood. 2026;148:229-244.
   PubMed     Abstract available
   
   
   
10. UCHIDA T, Shide K, Kameda T, Ozono Y, et al
    Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.
    Blood. 2026 Jul 2:blood.2025032693. doi: 10.1182/blood.2025032693.
    PubMed     Abstract available
    
    
    June 2026
11. DUNAWAY LS, Nyshadham S, Loeb SA, O'Donnell BL, et al
    Arterial iron regulates vasodilation during anemia via endothelial holo alpha-globin.
    Blood. 2026 Jun 29:blood.2025032905. doi: 10.1182/blood.2025032905.
    PubMed     Abstract available
    
    
    
12. FATTIZZO B, Miyakawa Y, Broome C
    Sutimlimab vs B-cell-targeted therapy in cold agglutinin disease: which is the optimal approach?
    Blood. 2026;147:3135-3143.
    PubMed     Abstract available
    
    
    
13. ZHI H, Sheridan D, Newman PJ, Newman DK, et al
    Transfusing HPA-mismatched platelets to mimic fetomaternal hemorrhage elicits fetal/neonatal alloimmune thrombocytopenia.
    Blood. 2026;147:2970-2980.
    PubMed     Abstract available
    
    
    
14. ESKANDARI N, Pappano E, Ruiz MAD, Mahmud N, et al
    Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease.
    Blood. 2026 Jun 1:blood.2026033813. doi: 10.1182/blood.2026033813.
    PubMed     Abstract available
    
    
    May 2026
15. LING T, Bezavada L, Mehmood R, Zhang K, et al
    The GATA1 N terminus coordinates metabolic reprogramming in erythropoiesis.
    Blood. 2026;147:2666-2681.
    PubMed     Abstract available
    
    
    
16. ZENG YH, Li YH, Yuan RY, Zuo DD, et al
    Biallelic loss-of-function mutations in BPNT1 cause vitamin B12-dependent megaloblastic anemia.
    Blood. 2026 May 21:blood.2026033550. doi: 10.1182/blood.2026033550.
    PubMed     Abstract available
    
    
    
17. HOLLAND H, Boothby A
    Thymoma-associated aplastic anemia with concurrent Good syndrome.
    Blood. 2026;147:2554.
    PubMed    
    
    
    
18. KWIATKOWSKI JL, Thompson AA, Schneiderman J, Thuret I, et al
    Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent beta-thalassemia.
    Blood. 2026;147:2203-2214.
    PubMed     Abstract available
    
    
    April 2026
19. 
    An X. Rbm38 binds Fech pre-mRNA to prevent anemia and porphyria. Blood. 2025;146(25):3016-3017.
    Blood. 2026;147:1886.
    PubMed    
    
    
    
20. SCHIMMER RR, Klemm N, Fullin J, Topcu E, et al
    Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.
    Blood. 2026;147:1663-1679.
    PubMed     Abstract available
    
    
    
21. LIU Y, Shayo S, Su S, Bao W, et al
    Heme-induced activation of the TLR3/TRIF-IFN-I-CCL2 pathway contributes to kidney injury in sickle cell disease.
    Blood. 2026;147:1624-1633.
    PubMed     Abstract available
    
    
    March 2026
22. GINDER GD, Shang S, Williams DC Jr
    DNA methylation matters: methylation of the gamma-globin (HBG) gene promoters is required for postnatal silencing of HbF.
    Blood. 2026;147:1416-1422.
    PubMed     Abstract available
    
    
    
23. ULLOA J, Wuichet K, Rashkin SR, Pershad Y, et al
    Increased prevalence of clonal hematopoiesis in children with sickle cell disease.
    Blood. 2026;147:1447-1455.
    PubMed     Abstract available
    
    
    
24. WAGNER SA, Panzer M, Pertler E, Redl S, et al
    Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia.
    Blood. 2026 Mar 18:blood.2025031806. doi: 10.1182/blood.2025031806.
    PubMed     Abstract available
    
    
    February 2026
25. BALBIN-CUESTA G, Drysdale C, Kerpet C, Yu L, et al
    p27Kip1 regulates gamma-globin production.
    Blood. 2026;147:973-986.
    PubMed     Abstract available
    
    
    January 2026
26. SOHAIL H, Collins JE, Chan KH, Alamgir MA, et al
    A Retrospective, Real-World Study of IV Iron Use to Treat Iron deficiency Anemia During Acute Infection.
    Blood. 2026 Jan 27:blood.2025031965. doi: 10.1182/blood.2025031965.
    PubMed     Abstract available
    
    
    
27. GUMMADI YK, Trottier AM
    Elevated serum erythropoietin level in JAK2+ polycythemia vera with small vessel Budd-Chiari syndrome.
    Blood. 2026;147:316.
    PubMed    
    
    
    December 2025
28. RUITER TJJ, van Oirschot BA, Waanders E, Koop K, et al
    NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis.
    Blood. 2025;146:3246-3249.
    PubMed     Abstract available
    
    
    
29. AN X
    Rbm38 binds Fech pre-mRNA to prevent anemia and porphyria.
    Blood. 2025;146:3016-3017.
    PubMed    
    
    
    November 2025
30. CHALUMEAU A, Bou Dames M, Fontana L, Amistadi S, et al
    A prime editing strategy to rewrite the gamma-globin promoters and reactivate fetal hemoglobin for sickle cell disease.
    Blood. 2025;146:2641-2655.
    PubMed     Abstract available
    
    
    
31. WILKS A, Steinberg MH, Frangoul H
    Gene therapy for HbSC disease and other compound heterozygous sickle hemoglobinopathies: a time for inclusion.
    Blood. 2025;146:2385-2391.
    PubMed     Abstract available
    
    
    October 2025
32. RONCADOR M, Bernard E, Hasserjian R, Boultwood J, et al
    A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.
    Blood. 2025;146:1883-1896.
    PubMed     Abstract available
    
    
    September 2025
33. RODRIGUES F, Hardouin G, El Hoss S, Ghoul A, et al
    VEXAS anemia is a mosaic erythroblastopenia.
    Blood. 2025 Sep 19:blood.2025029081. doi: 10.1182/blood.2025029081.
    PubMed     Abstract available
    
    
    
34. FALABREGUE M, Aurrand C, Cazaulon L, Boussetta N, et al
    Intestinal hepcidin overexpression promotes iron deficiency anemia and counteracts iron overload via DMT1 downregulation.
    Blood. 2025 Sep 9:blood.2025028370. doi: 10.1182/blood.2025028370.
    PubMed     Abstract available
    
    
    August 2025
35. SILVESTRI L
    When TNFalpha is out, IFN-gamma drives anemia of inflammation.
    Blood. 2025;146:908-910.
    PubMed    
    
    
    
36. BRUNNER PM
    The landscape of disease: mapping aplastic anemia.
    Blood. 2025;146:905-906.
    PubMed    
    
    
    
37. CARSON JL, Hebert PC, Alexander JH
    Counterpoint: the design and interpretation of blood transfusion randomized clinical trials.
    Blood. 2025;146:661-666.
    PubMed     Abstract available
    
    
    July 2025
38. FATTIZZO B, Versino F, Barcellini W
    Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice.
    Blood. 2025;146:411-421.
    PubMed     Abstract available
    
    
    
39. WANG Y, Yu L, Deng K, Packiarajan M, et al
    Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model.
    Blood. 2025;146:356-368.
    PubMed     Abstract available
    
    
    
40. YU H, Signer RAJ
    Proteostasis disruption in inherited bone marrow failure syndromes.
    Blood. 2025;146:304-317.
    PubMed     Abstract available
    
    
    
41. DUVAL R, Soudry A, De Oliveira Rios J, Linguet SL, et al
    The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Csa/Csb red cell antigens.
    Blood. 2025;146:247-253.
    PubMed     Abstract available
    
    
    
42. SETAYESH T, Chi M, Oestreicher Z, Sakabe M, et al
    A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea.
    Blood. 2025;146:13-28.
    PubMed     Abstract available
    
    
    June 2025
43. ANDOLFO I, Iolascon A, Russo R
    The evolving landscape of hereditary stomatocytosis.
    Blood. 2025;145:3089-3100.
    PubMed     Abstract available
    
    
    
44. LUZZATTO L, Nakao S
    Pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Blood. 2025;145:3077-3088.
    PubMed     Abstract available
    
    
    
45. GUERRA A, Lo Presti V, Chen DW, Martins AC, et al
    TNFalpha signaling restores steady-state hematopoiesis in a TNFalphaKO mouse model of anemia of inflammation.
    Blood. 2025 Jun 13:blood.2025029352. doi: 10.1182/blood.2025029352.
    PubMed     Abstract available
    
    
    
46. SUN R, Srivastava A, Zapater JL, Njoku F, et al
    Diabetes mellitus and APOL1 genotype increase the risk for chronic kidney disease progression in sickle cell disease.
    Blood. 2025;145:2927-2930.
    PubMed     Abstract available
    
    
    May 2025
47. POOL ES, Luk SJ, IJsselsteijn ME, van Unen V, et al
    Imaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic Anemia.
    Blood. 2025 May 22:blood.2025028723. doi: 10.1182/blood.2025028723.
    PubMed     Abstract available
    
    
    
48. CHOU ST, Hendrickson JE
    How I treat challenging transfusion cases in sickle cell disease.
    Blood. 2025;145:2257-2265.
    PubMed     Abstract available
    
    
    
49. BERI D, Rodriguez M, Singh M, McLaughlin D, et al
    Babesiosis and sickle red blood cells: loss of deformability, altered osmotic fragility, and hypervesiculation.
    Blood. 2025;145:2202-2213.
    PubMed     Abstract available
    
    
    
50. GAO Z, Pan H, Zhang L, Li W, et al
    Targeting CD38 with Daratumumab for Platelet Transfusion Refractoriness in Aplastic Anemia.
    Blood. 2025 May 7:blood.2025029006. doi: 10.1182/blood.2025029006.
    PubMed     Abstract available
    
    
    April 2025
51. FEDERTI E, Mattoscio D, Recchiuti A, Matte A, et al
    17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice.
    Blood. 2025;145:1915-1928.
    PubMed     Abstract available
    
    
    March 2025
52. WEEKS LD, Wilson AM, Naik RP, Efebera Y, et al
    Sickle cell trait does not cause "sickle cell crisis" leading to exertion-related death: a systematic review.
    Blood. 2025;145:1345-1352.
    PubMed     Abstract available
    
    
    
53. GIBSON NM, Khandros E, Elgarten CW, Worster E, et al
    Impact of HLA Alloimmunization in Gene-Modified Autologous Stem Cell Transplant For Transfusion-Dependent Thalassemia.
    Blood. 2025 Mar 16:blood.2024027034. doi: 10.1182/blood.2024027034.
    PubMed     Abstract available
    
    
    
54. IDRIS IM, Yusuf AA, Ismail II, Borodo AM, et al
    A Controlled Trial for Preventing Priapism in Sickle Cell Anemia: Hydroxyurea plus Placebo vs Hydroxyurea plus Tadalafil.
    Blood. 2025 Mar 12:blood.2024027898. doi: 10.1182/blood.2024027898.
    PubMed     Abstract available
    
    
    
55. LONG Y, Zhang Q, Ling L, Zhuang Y, et al
    Mutations in AMBRA1 aggravate beta-thalassemia by impairing autophagy-mediated clearance of free alpha-globin.
    Blood. 2025;145:1074-1088.
    PubMed     Abstract available
    
    
    February 2025
56. KULASEKARARAJ A, Griffin M, Piatek C, Shammo J, et al
    Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.
    Blood. 2025;145:811-822.
    PubMed     Abstract available
    
    
    
57. DUCAMP S, Campagna DR, Sendamarai A, Schmidt P, et al
    X-linked sideroblastic anemia in females.
    Blood. 2025 Feb 5:blood.2024024475. doi: 10.1182/blood.2024024475.
    PubMed     Abstract available
    
    
    January 2025
58. ABAZA Y, DeZern AE
    Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS.
    Blood. 2025;145:469-474.
    PubMed     Abstract available
    
    
    
59. 
    Montoro J, Eikema D-J, Tuffnell J, et al. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood. 2024;144(3):323-333.
    Blood. 2025;145:456.
    PubMed    
    
    
    
60. SU S, Bao W, Liu Y, Shi PA, et al
    IFN-I promotes T-cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD.
    Blood. 2025;145:334-347.
    PubMed     Abstract available
    
    
    
61. JAIN AG, Gerds AT
    How I Treat Anemia in Myelofibrosis.
    Blood. 2025 Jan 14:blood.2023022414. doi: 10.1182/blood.2023022414.
    PubMed     Abstract available
    
    
    
62. CHANTHONG S, Charoenkwan P
    Parvovirus B19-induced autoimmune hemolytic anemia in hereditary elliptocytosis.
    Blood. 2025;145:141.
    PubMed    
    
    
    
63. ITO S, Chetlapalli K, Wang D, Potnis KC, et al
    Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria.
    Blood. 2025;145:127-140.
    PubMed     Abstract available
    
    
    December 2024
64. SHARMA A
    How I treat sickle cell disease with gene therapy.
    Blood. 2024;144:2693-2705.
    PubMed     Abstract available
    
    
    
65. COLE MA, Ranjan N, Gerber GF, Pan XZ, et al
    Complement biosensors identify a classical pathway stimulus in complement-mediated thrombotic microangiopathy.
    Blood. 2024;144:2528-2545.
    PubMed     Abstract available
    
    
    
66. OLUWOLE O, Brunson AM, Adesina OO, Willen SM, et al
    Rates of strokes in Californians with sickle cell disease in the post-STOP era.
    Blood. 2024;144:2517-2527.
    PubMed     Abstract available
    
    
    
67. CASTRUCCIO CASTRACANI C, Breda L, Papp TE, Guerra A, et al
    An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA.
    Blood. 2024 Dec 10:blood.2024025846. doi: 10.1182/blood.2024025846.
    PubMed     Abstract available
    
    
    
68. LANGER AL, Goggins BB, Esrick EB, Fell G, et al
    beta-Thalassemia minor is associated with high rates of worsening anemia in pregnancy.
    Blood. 2024 Dec 9:blood.2024026736. doi: 10.1182/blood.2024026736.
    PubMed     Abstract available
    
    
    November 2024
69. KELLY C, Kumar R
    Pancreatitis-associated thrombotic microangiopathic hematolytic anemia with thrombocytopenia in a child.
    Blood. 2024;144:2270.
    PubMed    
    
    
    
70. CARUSO C, Cheng X, Michaud ME, Szafraniec HM, et al
    Less-deformable erythrocyte subpopulations biomechanically induce endothelial inflammation in sickle cell disease.
    Blood. 2024;144:2050-2062.
    PubMed     Abstract available
    
    
    
71. CHOU ST, Mewha J, Friedman DF, Lazariu V, et al
    Genotyped RhD+ red cells for D-positive patients with sickle cell disease with conventional RHD and unexpected anti-D.
    Blood. 2024;144:2045-2049.
    PubMed     Abstract available
    
    
    
72. ROMAN E, Fattizzo B, Shum MK, Hanna WT, et al
    Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia.
    Blood. 2024 Nov 1:blood.2023022549. doi: 10.1182/blood.2023022549.
    PubMed     Abstract available
    
    
    October 2024
73. BAJEL A
    Anemia response in myelofibrosis revisited.
    Blood. 2024;144:1759-1760.
    PubMed    
    
    
    
74. BAUER DE
    Genetic medicine gestating for alpha-thalassemia.
    Blood. 2024;144:1554-1556.
    PubMed    
    
    
    
75. CHAPPELL ME, Breda L, Tricoli L, Guerra A, et al
    Use of HSC-targeted LNP to generate a mouse model of lethal alpha-thalassemia and treatment via lentiviral gene therapy.
    Blood. 2024;144:1633-1645.
    PubMed     Abstract available
    
    
    
76. SHOPSOWITZ K, Moshref Razavi H
    A rare glimpse of Fessas bodies in a patient with beta-thalassemia major postsplenectomy.
    Blood. 2024;144:1543.
    PubMed    
    
    
    September 2024
77. VADIVELAN A, Doyle EK, Carson S, Denton C, et al
    Significant pituitary siderosis is common in transfusion-dependent sickle cell disease.
    Blood. 2024;144:1457-1459.
    PubMed     Abstract available
    
    
    
78. DUCAMP S, Sendamarai AK, Campagna DR, Chin DWL, et al
    Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine.
    Blood. 2024;144:1418-1432.
    PubMed     Abstract available
    
    
    
79. 
    Transplant outcome in pediatric Fanconi anemia.
    Blood. 2024;144:1350.
    PubMed    
    
    
    
80. SATTY AM
    Fanconi anemia: realizing hematopoietic cure.
    Blood. 2024;144:1245-1246.
    PubMed    
    
    
    
81. NATANSON C, Applefeld WN, Klein HG
    Hemoglobin-based Transfusion Strategies for Cardiovascular - and Other Diseases: Restrictive, Liberal, or Neither?
    Blood. 2024 Sep 18:blood.2024025927. doi: 10.1182/blood.2024025927.
    PubMed     Abstract available
    
    
    
82. KIM MG, Yu K, Yeh CY, Fouda R, et al
    Low-intensity transcranial focused ultrasound suppresses pain by modulating pain-processing brain circuits.
    Blood. 2024;144:1101-1115.
    PubMed     Abstract available
    
    
    August 2024
83. PINTO VM, Mazzi F, De Franceschi L
    Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders.
    Blood. 2024;144:853-866.
    PubMed     Abstract available
    
    
    
84. KHANDROS E, Blobel GA
    Elevating fetal hemoglobin: recently discovered regulators and mechanisms.
    Blood. 2024;144:845-852.
    PubMed     Abstract available
    
    
    
85. AMID A, Liu S, Babbs C, Higgs DR, et al
    Hemoglobin Bart's hydrops fetalis: charting the past and envisioning the future.
    Blood. 2024;144:822-833.
    PubMed     Abstract available
    
    
    
86. TEFFERI A, Barosi G, Passamonti F, Hernandez-Boluda JC, et al
    Proposals for Revised International Working Group-European LeukemiaNet Criteria for Anemia Response in Myelofibrosis.
    Blood. 2024 Aug 8:blood.2024025802. doi: 10.1182/blood.2024025802.
    PubMed     Abstract available
    
    
    
87. SHARMA A, Selukar S, Bi Y, Merlocco A, et al
    Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease.
    Blood. 2024;144:672-675.
    PubMed     Abstract available
    
    
    
88. WANG B, Shi D, Yang S, Lian Y, et al
    Mitochondrial tRNA pseudouridylation governs erythropoiesis.
    Blood. 2024;144:657-671.
    PubMed     Abstract available
    
    
    
89. SPARKENBAUGH EM
    EPCR shedding light on sickle nephropathy.
    Blood. 2024;144:472-474.
    PubMed    
    
    
    
90. CHEN Q, Hazra R, Crosby D, Lenhart D, et al
    Heme-induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice.
    Blood. 2024;144:552-564.
    PubMed     Abstract available
    
    
    July 2024
91. 
    Alternative donors in severe aplastic anemia.
    Blood. 2024;144:343.
    PubMed    
    
    
    
92. DEI ZOTTI F, Qiu A, D'Agati VD, Jagnarine S, et al
    Mitigation of Checkpoint Inhibitor-Induced Autoimmune Hemolytic Anemia through Modulation of Purinergic Signaling.
    Blood. 2024 Jul 16:blood.2024024230. doi: 10.1182/blood.2024024230.
    PubMed     Abstract available
    
    
    
93. SZER J
    Thrombosis in PNH: largely gone, but not forgotten.
    Blood. 2024;144:125-126.
    PubMed    
    
    
    
94. GURNARI C, Awada H, Pagliuca S, Dima D, et al
    Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysis.
    Blood. 2024;144:145-155.
    PubMed     Abstract available
    
    
    
95. LUM SH, Eikema DJ, Piepenbroek B, Wynn R, et al
    Outcome of Hematopoietic Stem Cell Transplantation in 813 Pediatric Patients with Fanconi Anemia.
    Blood. 2024 Jul 5:blood.2023022751. doi: 10.1182/blood.2023022751.
    PubMed     Abstract available
    
    
    
96. CORDEIL S, Jallades L
    Polycythemia revealing PIEZO1 hereditary xerocytosis.
    Blood. 2024;144:123.
    PubMed    
    
    
    June 2024
97. JACOBSOHN DA
    Dare mighty things for SCD.
    Blood. 2024;143:2569-2570.
    PubMed    
    
    
    
98. CHONAT S, Stowell SR
    COping with acute sickle cell hemolysis.
    Blood. 2024;143:2452-2453.
    PubMed    
    
    
    
99. NGUYEN KA, Matte A, Foresti R, Federti E, et al
    An oral carbon monoxide-releasing molecule protects against acute hyperhemolysis in sickle cell disease.
    Blood. 2024;143:2544-2558.
    PubMed     Abstract available
    
    
    May 2024
100. BROTHERS RO, Turrentine KB, Akbar M, Triplett S, et al
     The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease.
     Blood. 2024;143:2145-2151.
     PubMed     Abstract available
     
     
     
101. SADLER KE, Price TJ
     A humanized focus on sickle cell pain.
     Blood. 2024;143:2016-2017.
     PubMed    
     
     
     
102. ALLISON RL, Welby E, Ehlers V, Burand A, et al
     Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma.
     Blood. 2024;143:2037-2052.
     PubMed     Abstract available
     
     
     April 2024
103. MONTORO J, Eikema DJ, Tuffnell J, Potter V, et al
     Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.
     Blood. 2024 Apr 21:blood.2024024173. doi: 10.1182/blood.2024024173.
     PubMed     Abstract available
     
     
     
104. DEZERN AE
     A way to "mimic" the pathophysiology of acquired SAA.
     Blood. 2024;143:1318-1320.
     PubMed    
     
     
     
105. GORDEUK VR
     Glad tidings and joy for children with SCA.
     Blood. 2024;143:1326-1327.
     PubMed    
     
     
     March 2024
106. MAJUMDER R, Mohammad MA
     Sickle cell anemia: hepatic macrophages to the rescue.
     Blood. 2024;143:1209-1210.
     PubMed    
     
     
     
107. SILVESTRI L
     Ironing erythroid cells takes FLG1 and ERFE to tango.
     Blood. 2024;143:1208-1209.
     PubMed    
     
     
     
108. SZER J
     C5 inhibition in PNH: still effective and safe.
     Blood. 2024;143:1064-1065.
     PubMed    
     
     
     
109. KELLY RJ, Holt M, Vidler J, Arnold LM, et al
     Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria.
     Blood. 2024;143:1157-1166.
     PubMed     Abstract available
     
     
     
110. KASSIM AA, de la Fuente J, Nur E, Wilkerson K, et al
     An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
     Blood. 2024 Mar 17:blood.2023023301. doi: 10.1182/blood.2023023301.
     PubMed     Abstract available
     
     
     
111. NOGUCHI CT
     Hemolysis impairs sickle cell erythropoiesis.
     Blood. 2024;143:947-949.
     PubMed    
     
     
     
112. BENZ EJ JR, Silberstein LE, Panepinto J
     "Treatment with curative intent": the emergence of genetic therapies for sickle cell anemia.
     Blood. 2024;143:967-970.
     PubMed     Abstract available
     
     
     
113. LIU W, Wu Y, Wei H, Ma J, et al
     Lactate administration improves laboratory parameters in murine models of iron overload.
     Blood. 2024;143:1045-1049.
     PubMed     Abstract available
     
     
     
114. HAN Y, Gao C, Liu Y, Zhang H, et al
     Hemolysis-driven IFNalpha production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
     Blood. 2024;143:1018-1031.
     PubMed     Abstract available
     
     
     
115. COATES TD
     Higher hemoglobin is better in thalassemia.
     Blood. 2024;143:842-844.
     PubMed    
     
     
     
116. PAREKH DS, Eaton WA, Thein SL
     Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
     Blood. 2024;143:866-871.
     PubMed     Abstract available
     
     
     
117. MUSALLAM KM, Barella S, Origa R, Ferrero GB, et al
     Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent beta-thalassemia.
     Blood. 2024;143:930-932.
     PubMed    
     
     
     
118. SAHA A, Palchaudhuri R, Lanieri L, Hyzy S, et al
     Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice.
     Blood. 2024 Mar 6:blood.2023023549. doi: 10.1182/blood.2023023549.
     PubMed     Abstract available
     
     
     February 2024
119. FOGERTY AE, Kuter DJ
     How I treat thrombocytopenia in pregnancy.
     Blood. 2024;143:747-756.
     PubMed     Abstract available
     
     
     
120. JAMES AH, Strouse JJ
     How I treat sickle cell disease in pregnancy.
     Blood. 2024;143:769-776.
     PubMed     Abstract available
     
     
     
121. ORTEL TL
     Introduction to a How I Treat series on hematologic complications in pregnancy.
     Blood. 2024;143:739-740.
     PubMed    
     
     
     
122. D'SA S, Vos JMI, Barcellini W, Wardecki M, et al
     Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study.
     Blood. 2024;143:713-720.
     PubMed     Abstract available
     
     
     
123. NINGTYAS DC, Leitner F, Sohail H, Thong YL, et al
     Platelets mediate the clearance of senescent red blood cells by forming prophagocytic platelet-cell complexes.
     Blood. 2024;143:535-547.
     PubMed     Abstract available
     
     
     January 2024
124. BEN HAMZA A, Welters C, Stadler S, Bruggemann M, et al
     Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
     Blood. 2024 Jan 26:blood.2023023142. doi: 10.1182/blood.2023023142.
     PubMed     Abstract available
     
     
     
125. GUIZOUARN H
     Mechanosensation and lipid scrambling news.
     Blood. 2024;143:300-301.
     PubMed    
     
     
     
126. 
     Keith J, Christakopoulos GE, Fernandez AG, et al. Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin. Blood. 2023;142(10):918-932.
     Blood. 2024;143:377.
     PubMed    
     
     
     
127. LIANG P, Zhang Y, Wan YCS, Ma S, et al
     Deciphering and disrupting PIEZO1-TMEM16F interplay in hereditary xerocytosis.
     Blood. 2024;143:357-369.
     PubMed     Abstract available
     
     
     
128. NAMAZZI R, Bond C, Conroy A, Datta D, et al
     Hydroxyurea reduces infections in children with sickle cell anemia in Uganda.
     Blood. 2024 Jan 3:blood.2023021575. doi: 10.1182/blood.2023021575.
     PubMed     Abstract available
     
     
     December 2023
129. HELLSTROM-LINDBERG ES, Kroger N
     Clinical decision-making and treatment of myelodysplastic syndromes.
     Blood. 2023;142:2268-2281.
     PubMed     Abstract available
     
     
     
130. SHI H, Gao L, Kirby N, Shao B, et al
     Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.
     Blood. 2023 Dec 24:blood.2023021583. doi: 10.1182/blood.2023021583.
     PubMed     Abstract available
     
     
     
131. SARDO U, Perrier P, Cormier K, Sotin M, et al
     The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.
     Blood. 2023 Dec 24:blood.2023022724. doi: 10.1182/blood.2023022724.
     PubMed     Abstract available
     
     
     
132. ATAGA KI
     The challenge of clinical end points in sickle cell disease.
     Blood. 2023;142:2047-2054.
     PubMed     Abstract available
     
     
     November 2023
133. SPARKENBAUGH E, Little J
     Cold comfort in sickle cell disease.
     Blood. 2023;142:1854-1856.
     PubMed    
     
     
     
134. CAI J, Lee J
     Cold agglutinin syndrome with unexpected bone marrow CD5+ diffuse large B-cell lymphoma.
     Blood. 2023;142:1935.
     PubMed    
     
     
     
135. IVY ZK, Belcher JD, Khasabova IA, Chen C, et al
     Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
     Blood. 2023;142:1918-1927.
     PubMed     Abstract available
     
     
     
136. DENTON CC, Vodala S, Veluswamy S, Hofstra TC, et al
     Splenic iron decreases without change in volume or liver parameters during luspatercept therapy.
     Blood. 2023;142:1932-1934.
     PubMed     Abstract available
     
     
     October 2023
137. VAN DE KAR NCAJ, Wetzels JFM
     Narrowing the knowledge gap in atypical HUS.
     Blood. 2023;142:1334-1335.
     PubMed    
     
     
     
138. 
     C5 inhibition in aHUS.
     Blood. 2023;142:1406.
     PubMed    
     
     
     
139. BROCKLEBANK V, Walsh PR, Smith-Jackson K, Hallam TM, et al
     Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
     Blood. 2023;142:1371-1386.
     PubMed     Abstract available
     
     
     
140. 
     d'Humieres T, Saba J, Savale L, et al. Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death. Blood. 2023;142(5):409-420.
     Blood. 2023;142:1329.
     PubMed    
     
     
     
141. WU Z, Young NS
     Single-cell genomics in acquired bone marrow failure syndromes.
     Blood. 2023;142:1193-1207.
     PubMed     Abstract available
     
     
     September 2023
142. SALIBA AN, Musallam KM, Taher AT
     How I treat non-transfusion-dependent beta-thalassemia.
     Blood. 2023;142:949-960.
     PubMed     Abstract available
     
     
     
143. BABBS C
     The incredible ULK improves beta-thalassemia.
     Blood. 2023;142:862-863.
     PubMed    
     
     
     
144. KEITH J, Christakopoulos GE, Fernandez AG, Yao Y, et al
     Loss of miR-144/451 alleviates beta-thalassemia by stimulating ULK1-mediated autophagy of free alpha-globin.
     Blood. 2023;142:918-932.
     PubMed     Abstract available
     
     
     August 2023
145. GODLEY LA
     Germ line risk variants: beyond cancer.
     Blood. 2023;142:616-617.
     PubMed    
     
     
     
146. MOLTENI E, Bono E, Galli A, Elena C, et al
     Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
     Blood. 2023;142:643-657.
     PubMed     Abstract available
     
     
     
147. JAVA A, Atkinson J, Hu Z, Pozzi N, et al
     Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I.
     Blood. 2023;142:607-610.
     PubMed     Abstract available
     
     
     
148. DESAI AA
     Ventricular arrhythmias in sickle cell anemia.
     Blood. 2023;142:399-400.
     PubMed    
     
     
     July 2023
149. XI C, Pang J, Zhi W, Chang CS, et al
     Nrf2 sensitizes ferroptosis through l-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease.
     Blood. 2023;142:382-396.
     PubMed     Abstract available
     
     
     
150. TUBMAN VN, Mohandas N, Abrams CS
     New ASH initiatives to improve patient care in the long-overlooked sickle cell disease.
     Blood. 2023;142:230-234.
     PubMed     Abstract available
     
     
     
151. SIMONEAU J, Shah YM
     Ironing out beta-thalassemia during pregnancy.
     Blood. 2023;142:128-129.
     PubMed    
     
     
     
152. YU Y, Woloshun RR, Lee JK, Ebea PO, et al
     Fetal factors disrupt placental and maternal iron homeostasis in murine beta-thalassemia.
     Blood. 2023;142:185-196.
     PubMed     Abstract available
     
     
     June 2023
153. BRAMMER JE, Ballen K, Sokol L, Querfeld C, et al
     Effective Treatment with the Selective Cytokine Inhibitor BNZ-1 Reveals the Cytokine Dependency of T-LGL Leukemia.
     Blood. 2023 Jun 23:blood.2022017643. doi: 10.1182/blood.2022017643.
     PubMed     Abstract available
     
     
     
154. DEEG HJ
     Reward from half a match.
     Blood. 2023;141:3009-3010.
     PubMed    
     
     
     
155. TOLOSANO E
     Heme and macrophages: a complicated liaison.
     Blood. 2023;141:3015-3017.
     PubMed    
     
     
     
156. FERRER-VICENS I, Ferguson DCJ, Wilson MC, Heesom KJ, et al
     A novel human cellular model of CDA IV enables comprehensive analysis revealing the molecular basis of the disease phenotype.
     Blood. 2023;141:3039-3054.
     PubMed     Abstract available
     
     
     
157. SHARMA R, Antypiuk A, Vance SZ, Manwani D, et al
     Macrophage metabolic rewiring improves heme-suppressed efferocytosis and tissue damage in sickle cell disease.
     Blood. 2023;141:3091-3108.
     PubMed     Abstract available
     
     
     
158. LAM WK, Yip SF
     Cytopenic AML with marrow fibrosis and multihit TP53 abnormalities.
     Blood. 2023;141:3006.
     PubMed    
     
     
     
159. DEAN A
     Help on the way to unsilence HbF.
     Blood. 2023;141:2670-2672.
     PubMed    
     
     
     
160. DEAN A
     Help on the way to unsilence HbF.
     Blood. 2023;141:2670-2672.
     PubMed    
     
     
     May 2023
161. BENJAMIN RJ
     Cytosolic antigens prime RBC alloantibodies.
     Blood. 2023;141:2550-2551.
     PubMed    
     
     
     
162. D'HUMIERES T, Saba J, Savale L, Dupuy M, et al
     Determinants of Ventricular Arrhythmias in Sickle Cell Anemia: Towards a Better Prevention of Sudden Cardiac Death.
     Blood. 2023 May 22:blood.2022019571. doi: 10.1182/blood.2022019571.
     PubMed     Abstract available
     
     
     
163. HESLOP HE
     Introduction to a How I Treat series on emergent CAR T-cell toxicities.
     Blood. 2023;141:2405-2407.
     PubMed    
     
     
     April 2023
164. LI C, Georgakopoulou A, Newby GA, Chen PJ, et al
     In vivo HSC prime editing rescues sickle cell disease in a mouse model.
     Blood. 2023;141:2085-2099.
     PubMed     Abstract available
     
     
     
165. GUTIERREZ-RODRIGUES F, Munger E, Ma X, Groarke EM, et al
     Differential diagnosis of bone marrow failure syndromes guided by machine learning.
     Blood. 2023;141:2100-2113.
     PubMed     Abstract available
     
     
     
166. DEZERN A, Zahurak ML, Symons HJ, Cooke KR, et al
     Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
     Blood. 2023 Apr 21:blood.2023020435. doi: 10.1182/blood.2023020435.
     PubMed     Abstract available
     
     
     
167. LANGER AL
     Love's labor's lost? Fetal vs maternal AIHA outcomes.
     Blood. 2023;141:1906-1907.
     PubMed    
     
     
     
168. GURNARI C, Prata PH, Catto LFB, Durmaz A, et al
     IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.
     Blood. 2023 Apr 13:blood.2023020108. doi: 10.1182/blood.2023020108.
     PubMed    
     
     
     
169. SHET AS
     FXII and sickle cell: the clot thickens.
     Blood. 2023;141:1787-1789.
     PubMed    
     
     
     
170. RISITANO AM
     PNH and complement gene variants.
     Blood. 2023;141:1780-1782.
     PubMed    
     
     
     
171. SPARKENBAUGH EM, Henderson MW, Miller-Awe M, Abrams C, et al
     Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
     Blood. 2023;141:1871-1883.
     PubMed     Abstract available
     
     
     
172. PRATA PH, Galimard JE, Sicre de Fontbrune F, Duval A, et al
     Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
     Blood. 2023;141:1812-1816.
     PubMed     Abstract available
     
     
     
173. 
     Walter O, Cougoul P, Maquet J, et al. Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood. 2022;139(26):3771-3777.
     Blood. 2023;141:1778.
     PubMed    
     
     
     March 2023
174. SUKUMAR S, Sasa G
     Blocking COX unlocks response in GHDD.
     Blood. 2023;141:1497-1498.
     PubMed    
     
     
     
175. BROWN TJ, Barrett N, Meng H, Ricciotti E, et al
     Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia.
     Blood. 2023;141:1553-1559.
     PubMed     Abstract available
     
     
     
176. ODAME I
     HU for SCA in Africa: associated malaria benefit.
     Blood. 2023;141:1370-1371.
     PubMed    
     
     
     
177. HAKKARAINEN M, Kaaja I, Douglas SPM, Vulliamy TJ, et al
     The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia.
     Blood. 2023 Mar 23:blood.2022019425. doi: 10.1182/blood.2022019425.
     PubMed     Abstract available
     
     
     
178. HAMMOUDI N, Lionnet F
     Heart failure in SCA: still challenging.
     Blood. 2023;141:1248-1249.
     PubMed    
     
     
     
179. AYOUB PG, Kohn DB
     beta-Thalassemia: all about that base, no cutting.
     Blood. 2023;141:1098-1099.
     PubMed    
     
     
     
180. MATSON DR, Matkovic E
     Peripheral erythrophagocytosis in paroxysmal cold hemoglobinuria.
     Blood. 2023;141:1233.
     PubMed    
     
     
     
181. HARDOUIN G, Antoniou P, Martinucci P, Felix T, et al
     Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) beta-thalassemia mutation.
     Blood. 2023;141:1169-1179.
     PubMed     Abstract available
     
     
     
182. 
     Ludwig LS, Lareau CA, Bao EL, et al. Congenital anemia reveals distinct targeting mechanisms for master transcription factor GATA1. Blood. 2022;139(16):2534-2546.
     Blood. 2023;141:1094.
     PubMed    
     
     
     
183. FAKHOURI F, Schwotzer N, Fremeaux-Bacchi V
     How I diagnose and treat atypical hemolytic uremic syndrome.
     Blood. 2023;141:984-995.
     PubMed     Abstract available
     
     
     February 2023
184. QUINN CT
     Hydroxyurea: how much is enough?
     Blood. 2023;141:813-814.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum